Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656875 · ClinicalTrials.gov registry record · Phase 3
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
A Phase 3 study, sponsored by Trevena.
- Completed
- Registry status
- Phase 3
- Development phase
- 768
- Enrollment target
NCT02656875 is a Phase 3 study that has completed, run by Trevena. The registered enrollment target is 768 participants.
The verdict
NCT02656875, a Phase 3 study, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 768 participants
- Enrollment target
Study Summary
Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA (patient-controlled analgesia) administration, or both, as determined by the investigator, for a duration not to exceed 14 days.
Interventions
- DRUG TRV130
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 768 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02656875
The ClinicalTrials.gov registry entry for NCT02656875 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 768 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRV130 is the first listed.
NCT02656875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02656875 about?
NCT02656875 is a clinical study titled "A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain". Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA (patient-controlled analgesia) administration, or both, as determined by the investigato...
What is the current status of trial NCT02656875?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 768 participants. The study started on 2015-12. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02656875?
The interventions under investigation include: TRV130 (DRUG).
Who is sponsoring clinical trial NCT02656875?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.